New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review

Background: Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines. Objectives: To descri...

Full description

Saved in:
Bibliographic Details
Main Authors: Alhumaid, Saad, Al Mutair, Abbas, Rabaan, Ali A, AlShakhs, Fatemah M, Choudhary, Om Prakash, Yong, Shin Jie *, Nainu, Firzan, Khan, Amjad, Muhammad, Javed, Alhelal, Fadil, Al Khamees, Mohammed Hussain, Alsouaib, Hussian Ahmed, Al Majhad, Ahmed Salman, Al-Tarfi, Hassan Redha, ALyasin, Ali Hussain, Alatiyyah, Yaqoub Yousef, Alsultan, Ali Ahmed, Alessa, Mohammed Essa, Alessa, Mustafa Essa, Alissa, Mohammed Ahmed, Alsayegh, Emad Hassan, Alshakhs, Hassan N, Al Samaeel, Haidar Abdullah, AlShayeb, Rugayah Ahmed, Alnami, Dalal Ahmed, Alhassan, Hussain Ali, Alabdullah, Abdulaziz Abdullah, Alhmed, Ayat Hussain, AlDera, Faisal Hussain, Hajissa, Khalid, Al-Tawfiq, Jaffar A, Al-Omari, Awad
Format: Article
Published: BMC 2022
Subjects:
Online Access:http://eprints.sunway.edu.my/3056/
https://doi.org/10.1186/s12876-022-02507-3
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.sunway.eprints.3056
record_format eprints
spelling my.sunway.eprints.30562024-08-12T00:27:40Z http://eprints.sunway.edu.my/3056/ New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review Alhumaid, Saad Al Mutair, Abbas Rabaan, Ali A AlShakhs, Fatemah M Choudhary, Om Prakash Yong, Shin Jie * Nainu, Firzan Khan, Amjad Muhammad, Javed Alhelal, Fadil Al Khamees, Mohammed Hussain Alsouaib, Hussian Ahmed Al Majhad, Ahmed Salman Al-Tarfi, Hassan Redha ALyasin, Ali Hussain Alatiyyah, Yaqoub Yousef Alsultan, Ali Ahmed Alessa, Mohammed Essa Alessa, Mustafa Essa Alissa, Mohammed Ahmed Alsayegh, Emad Hassan Alshakhs, Hassan N Al Samaeel, Haidar Abdullah AlShayeb, Rugayah Ahmed Alnami, Dalal Ahmed Alhassan, Hussain Ali Alabdullah, Abdulaziz Abdullah Alhmed, Ayat Hussain AlDera, Faisal Hussain Hajissa, Khalid Al-Tawfiq, Jaffar A Al-Omari, Awad QP Physiology QR Microbiology RC Internal medicine Background: Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines. Objectives: To describe the results of a systematic review for new-onset and relapsed liver disease following COVID-19 vaccination. Methods: For this systematic review, we searched Proquest, Medline, Embase, PubMed, CINAHL, Wiley online library, Scopus and Nature through the Preferred Reporting Items for Systematic Reviews and Meta Analyses PRISMA guideline for studies on the incidence of new onset or relapsed liver diseases post-COVID-19 vaccination, published from December 1, 2020 to July 31, 2022, with English language restriction. Results: Two hundred seventy-five cases from one hundred and eighteen articles were included in the qualitative synthesis of this systematic review. Autoimmune hepatitis (138 cases) was the most frequent pathology observed post-COVID-19 vaccination, followed by portal vein thrombosis (52 cases), raised liver enzymes (26 cases) and liver injury (21 cases). Other cases include splanchnic vein thrombosis, acute cellular rejection of the liver, jaundice, hepatomegaly, acute hepatic failure and hepatic porphyria. Mortality was reported in any of the included cases for acute hepatic failure (n = 4, 50%), portal vein thrombosis (n = 25, 48.1%), splanchnic vein thrombosis (n = 6, 42.8%), jaundice (n = 1, 12.5%), raised liver enzymes (n = 2, 7.7%), and autoimmune hepatitis (n = 3, 2.2%). Most patients were easily treated without any serious complications, recovered and did not require long-term hepatic therapy. Conclusion: Reported evidence of liver diseases post-COIVD-19 vaccination should not discourage vaccination against this worldwide pandemic. The number of reported cases is relatively very small in relation to the hundreds of millions of vaccinations that have occurred and the protective benefits offered by COVID-19 vaccination far outweigh the risks. BMC 2022 Article PeerReviewed Alhumaid, Saad and Al Mutair, Abbas and Rabaan, Ali A and AlShakhs, Fatemah M and Choudhary, Om Prakash and Yong, Shin Jie * and Nainu, Firzan and Khan, Amjad and Muhammad, Javed and Alhelal, Fadil and Al Khamees, Mohammed Hussain and Alsouaib, Hussian Ahmed and Al Majhad, Ahmed Salman and Al-Tarfi, Hassan Redha and ALyasin, Ali Hussain and Alatiyyah, Yaqoub Yousef and Alsultan, Ali Ahmed and Alessa, Mohammed Essa and Alessa, Mustafa Essa and Alissa, Mohammed Ahmed and Alsayegh, Emad Hassan and Alshakhs, Hassan N and Al Samaeel, Haidar Abdullah and AlShayeb, Rugayah Ahmed and Alnami, Dalal Ahmed and Alhassan, Hussain Ali and Alabdullah, Abdulaziz Abdullah and Alhmed, Ayat Hussain and AlDera, Faisal Hussain and Hajissa, Khalid and Al-Tawfiq, Jaffar A and Al-Omari, Awad (2022) New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review. BMC Gastroenterology, 22. ISSN 1471-230X https://doi.org/10.1186/s12876-022-02507-3 10.1186/s12876-022-02507-3
institution Sunway University
building Sunway Campus Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Sunway University
content_source Sunway Institutional Repository
url_provider http://eprints.sunway.edu.my/
topic QP Physiology
QR Microbiology
RC Internal medicine
spellingShingle QP Physiology
QR Microbiology
RC Internal medicine
Alhumaid, Saad
Al Mutair, Abbas
Rabaan, Ali A
AlShakhs, Fatemah M
Choudhary, Om Prakash
Yong, Shin Jie *
Nainu, Firzan
Khan, Amjad
Muhammad, Javed
Alhelal, Fadil
Al Khamees, Mohammed Hussain
Alsouaib, Hussian Ahmed
Al Majhad, Ahmed Salman
Al-Tarfi, Hassan Redha
ALyasin, Ali Hussain
Alatiyyah, Yaqoub Yousef
Alsultan, Ali Ahmed
Alessa, Mohammed Essa
Alessa, Mustafa Essa
Alissa, Mohammed Ahmed
Alsayegh, Emad Hassan
Alshakhs, Hassan N
Al Samaeel, Haidar Abdullah
AlShayeb, Rugayah Ahmed
Alnami, Dalal Ahmed
Alhassan, Hussain Ali
Alabdullah, Abdulaziz Abdullah
Alhmed, Ayat Hussain
AlDera, Faisal Hussain
Hajissa, Khalid
Al-Tawfiq, Jaffar A
Al-Omari, Awad
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
description Background: Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines. Objectives: To describe the results of a systematic review for new-onset and relapsed liver disease following COVID-19 vaccination. Methods: For this systematic review, we searched Proquest, Medline, Embase, PubMed, CINAHL, Wiley online library, Scopus and Nature through the Preferred Reporting Items for Systematic Reviews and Meta Analyses PRISMA guideline for studies on the incidence of new onset or relapsed liver diseases post-COVID-19 vaccination, published from December 1, 2020 to July 31, 2022, with English language restriction. Results: Two hundred seventy-five cases from one hundred and eighteen articles were included in the qualitative synthesis of this systematic review. Autoimmune hepatitis (138 cases) was the most frequent pathology observed post-COVID-19 vaccination, followed by portal vein thrombosis (52 cases), raised liver enzymes (26 cases) and liver injury (21 cases). Other cases include splanchnic vein thrombosis, acute cellular rejection of the liver, jaundice, hepatomegaly, acute hepatic failure and hepatic porphyria. Mortality was reported in any of the included cases for acute hepatic failure (n = 4, 50%), portal vein thrombosis (n = 25, 48.1%), splanchnic vein thrombosis (n = 6, 42.8%), jaundice (n = 1, 12.5%), raised liver enzymes (n = 2, 7.7%), and autoimmune hepatitis (n = 3, 2.2%). Most patients were easily treated without any serious complications, recovered and did not require long-term hepatic therapy. Conclusion: Reported evidence of liver diseases post-COIVD-19 vaccination should not discourage vaccination against this worldwide pandemic. The number of reported cases is relatively very small in relation to the hundreds of millions of vaccinations that have occurred and the protective benefits offered by COVID-19 vaccination far outweigh the risks.
format Article
author Alhumaid, Saad
Al Mutair, Abbas
Rabaan, Ali A
AlShakhs, Fatemah M
Choudhary, Om Prakash
Yong, Shin Jie *
Nainu, Firzan
Khan, Amjad
Muhammad, Javed
Alhelal, Fadil
Al Khamees, Mohammed Hussain
Alsouaib, Hussian Ahmed
Al Majhad, Ahmed Salman
Al-Tarfi, Hassan Redha
ALyasin, Ali Hussain
Alatiyyah, Yaqoub Yousef
Alsultan, Ali Ahmed
Alessa, Mohammed Essa
Alessa, Mustafa Essa
Alissa, Mohammed Ahmed
Alsayegh, Emad Hassan
Alshakhs, Hassan N
Al Samaeel, Haidar Abdullah
AlShayeb, Rugayah Ahmed
Alnami, Dalal Ahmed
Alhassan, Hussain Ali
Alabdullah, Abdulaziz Abdullah
Alhmed, Ayat Hussain
AlDera, Faisal Hussain
Hajissa, Khalid
Al-Tawfiq, Jaffar A
Al-Omari, Awad
author_facet Alhumaid, Saad
Al Mutair, Abbas
Rabaan, Ali A
AlShakhs, Fatemah M
Choudhary, Om Prakash
Yong, Shin Jie *
Nainu, Firzan
Khan, Amjad
Muhammad, Javed
Alhelal, Fadil
Al Khamees, Mohammed Hussain
Alsouaib, Hussian Ahmed
Al Majhad, Ahmed Salman
Al-Tarfi, Hassan Redha
ALyasin, Ali Hussain
Alatiyyah, Yaqoub Yousef
Alsultan, Ali Ahmed
Alessa, Mohammed Essa
Alessa, Mustafa Essa
Alissa, Mohammed Ahmed
Alsayegh, Emad Hassan
Alshakhs, Hassan N
Al Samaeel, Haidar Abdullah
AlShayeb, Rugayah Ahmed
Alnami, Dalal Ahmed
Alhassan, Hussain Ali
Alabdullah, Abdulaziz Abdullah
Alhmed, Ayat Hussain
AlDera, Faisal Hussain
Hajissa, Khalid
Al-Tawfiq, Jaffar A
Al-Omari, Awad
author_sort Alhumaid, Saad
title New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
title_short New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
title_full New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
title_fullStr New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
title_full_unstemmed New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
title_sort new-onset and relapsed liver diseases following covid-19 vaccination: a systematic review
publisher BMC
publishDate 2022
url http://eprints.sunway.edu.my/3056/
https://doi.org/10.1186/s12876-022-02507-3
_version_ 1808975634779602944
score 13.211869